Connect with:
Monday / December 23. 2024
HomeAgrotechCorteva Agriscience signs agreement with Andermatt USA

Corteva Agriscience signs agreement with Andermatt USA

micro-lab-farms-opens-dedicated-rd-center-for-entrepreneurs
Image credit: PR Newswire

The multi-year agreement for two technologies will benefit US farmers

Corteva Agriscience and Andermatt USA signed a multi-year agreement for two technologies that will benefit US farmers. Andermatt USA is the US subsidiary of Andermatt Biocontrol AG, global pioneer in producing microbiological products for biological pest control.

 

As part of the agreement, Corteva receives an exclusive license to a bioinsecticide based on the naturally occurring insecticidal virus, Helicoverpa armigera nucleopolyhedrovirus. The active ingredient targets larvae of African cotton bollworm, corn earworm and other Helicoverpa species. The unique technology allows efficient and sustainable control of these pests, which damage crops including soybeans, cotton, sorghum and corn.

 

Corteva also receives an exclusive license to a bio fungicide that helps provide a disease-inhibiting protective shield around plants. Based on the active ingredient Bacillus velezensis (synonym B. amyloliquefaciens spp. plantarum), the biofungicide guards plants such as potatoes, fruits and vegetables against soil-borne pathogens including Rhizoctonia. Corteva will offer these technologies through its brands in the US market under the names Hearken bioinsecticide and Bexfond bio fungicide, respectively.

 

“This is another demonstration of Corteva Agriscience’s continuous commitment to providing farmers with a broad range of biological solutions. We are enabling additional tools for sustainable production, resistance management and residue management in exporting crops with proven, predictable performance; all of our biologicals are tested and meet Corteva Agriscience’s high standards in Research & Development,” said Susanne Wasson, President, Crop Protection Business Platform, Corteva Agriscience.

 

Corteva’s model for developing its best-in-class Biologicals portfolio combines external innovation, R&D collaboration, licensing, and distribution. This agreement demonstrates how Corteva is targeting collaborations that bring a broad range of external technologies, including well-established companies in the Biologicals space to expand access to a complete set of sustainable solutions in line with the Corteva Agriscience 2030 Sustainability Goals.

Share

No comments

leave a comment